Symrise, DE000SYM9999

Symrise stock holds at EUR 93.38 as buyback reaches 4,091,018 shares

Published on 09/29/2026 at 10:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Symrise stock posted EUR 2.539 billion in H1 2026 sales and a 21.8 percent adjusted EBITDA margin. Management reaffirmed 2%-4% organic growth for 2026.

Aquarellmalerei einer deutschen Flussstadt mit Chemiefabrik, Symrise AG DE000SYM9999
Symrise AG (DE000SYM9999) Aquarell zeigt Flussstadt Holzminden mit Fachwerkhäusern und Chemiefabrik am Ufer, Illustration mit AI erstellt.

Symrise stock (ISIN DE000SYM9999) was trading at EUR 93.38 on Xetra on September 29, 2026 at 9:57 a.m. CEST, with a 0.00 percent change. The latest capital-market update shows that Symrise bought 142,500 shares in the period through September 18, 2026, taking cumulative purchases since February to 4,091,018 shares, as Finanznachrichten reported on September 21, 2026.

Buyback reaches 4,091,018 shares

The latest purchase tranche represented 0.10 percent of share capital and had a weighted average price of EUR 89.6707, according to the September 21, 2026 release. The program gives Symrise a visible capital-allocation angle while the stock remains 1.71 percent below its 52-week high of EUR 95.00.

H1 sales reach EUR 2.539 billion

Symrise reported H1 2026 sales of EUR 2.539 billion and organic growth of 2.0 percent. The most important quarterly comparison was Q2 organic growth of 4.5 percent, up from a slight decline in Q1, while adjusted EBITDA reached EUR 553 million at a 21.8 percent margin, according to the Yahoo Finance transcript dated July 30, 2026.

Cash generation was another differentiator: adjusted business free cash flow rose 47.0 percent year over year to EUR 347 million, equal to a 13.7 percent margin. The counterweight is segment execution, with Scent and Care adjusted EBITDA down 6.7 percent to EUR 178 million and its margin at 17.7 percent in H1 2026.

Guidance stays at 2%-4%

Management reaffirmed 2026 organic sales growth of 2%-4%, an adjusted EBITDA margin of 21.5%-22.5% and an adjusted business free cash flow margin above 14.0%. That guidance places the 4.5 percent Q2 organic growth rate at the level needed to support the full-year range, while higher logistics and raw-material costs remain a margin consideration.

Analyst expectations add a second reference point. On September 1, 2026, MarketScreener reported that Jefferies raised its Symrise rating to Buy from Hold and lifted its price target to EUR 110 from EUR 80. The new target lies 17.81 percent above the EUR 93.38 Xetra price dated September 29, 2026.

Stock remains below EUR 95.00 high

Symrise had a market capitalization of EUR 12.8 billion and volume of 10,884 shares at the September 29, 2026 snapshot. Its 52-week range was EUR 64.70 to EUR 95.00, leaving the current quote EUR 28.68 above the low and EUR 1.62 below the high.

Symrise's investor-relations calendar lists October 28, 2026 for the Interim Group Report January to September 2026, providing the next dated operating checkpoint, according to Symrise. The next report will test whether Q2's 4.5 percent organic growth pace carries into the second half.

Symrise stock key data

  • Company: Symrise AG
  • ISIN: DE000SYM9999
  • WKN: SYM999
  • Ticker: SY1
  • Trading venue: Xetra
  • Price (as of September 29, 2026, 9:57 a.m. CEST): EUR 93.38
  • Market capitalization: EUR 12.8 billion (as of September 29, 2026)
  • 52-week range: EUR 64.70-EUR 95.00 (as of September 29, 2026)
  • Sector / Industry: Basic Materials / Specialty Chemicals
  • Index membership: DAX
  • Next earnings date: October 28, 2026

More news and analyses on Symrise stock

Disclaimer...

en | DE000SYM9999 | SYMRISE | boerse | 70196984 | bgmi